X
View Mobile Number64% Response Rate

Anti Cancer Capsules

Our product range includes a wide range of Lynparza Olaparib 150mg, Alectinib 150 Mg Capsules and Alecensa Alectinib 150 Mg Capsules.

  • Lynparza Olaparib 150mg
  • Lynparza Olaparib 150mg
  • Lynparza Olaparib 150mg
  • Lynparza Olaparib 150mg
Lynparza Olaparib 150mg
Interested in this product?
Get Best Quote

Lynparza Olaparib 150mg

Rs 90,000 / BoxGet Latest Price

Minimum Order Quantity: 1 Box

Product Brochure Watch Video

Grade StandardALOPATHIC
Packaging TypeBOX
Country of OriginMade in India
Packaging Size7*8 TAB
BrandLYNPARZA
Drug NameOlaparib
Dose/Strength150 MG
Usage/ApplicationPersonal

Generic Content-Olaparib , Manufactured By:Astrazeneca

Olaparib is an FDA-approved targeted therapy for cancer. It is a PARP inhibitor, inhibiting poly ADP ribose polymerase, an enzyme involved in DNA repair. It acts against cancers in people with hereditary BRCA1 or BRCA2 mutations, which include some ovarian, breast, and prostate cancers.

Olaparib is indicated as monotherapy for the treatment of metastatic or locally advanced cancer in patients whose tumors are resistant



Additional Information:

  • Item Code: 544
  • Production Capacity: 10 BOX
  • Delivery Time: 5-6

View Complete Details

Yes, I am interested!

Alectinib 150 Mg Capsules
Interested in this product?
Get Best Quote

Alectinib 150 Mg Capsules

Rs 1,000 / BoxGet Latest Price

Packaging Size1*120 TAB
BrandAlectinib
CompositionALECTINIB
ManufacturerROCHE
Treatmentcancer
Prescription/Non prescriptionPrescription
Deals inPCD Pharma
FormTablet
Shelf life2 YEARS
Country of OriginMade in India

Alectinib is an oral drug that blocks the activity of anaplastic lymphoma kinase and is used to treat non-small-cell lung cancer. It was developed by Chugai Pharmaceutical Co. Japan, which is part of the Hoffmann-La Roche group

View Complete Details

Yes, I am interested!

Alecensa Alectinib 150 Mg Capsules
Interested in this product?
Get Best Quote

Alecensa Alectinib 150 Mg Capsules

Rs 1,000 / BoxGet Latest Price

Packaging SizeBOX
BrandROCHE
CompositionALECTINIB
ManufacturerROCHE
Treatmentcancer
Prescription/Non prescriptionPrescription

Alectinib is an oral drug that blocks the activity of anaplastic lymphoma kinase and is used to treat non-small-cell lung cancer. It was developed by Chugai Pharmaceutical Co. Japan, which is part of the Hoffmann-La Roche group.

View Complete Details

Yes, I am interested!

Get in touch with us

Reach Us

Hiwi Healthcare Private LimitedOpposite Siddhivinayak Fibers, Aara Road, Krishna Nagar, Moga-142001, Punjab, India

ANKIT MITTAL (Director)

View Mobile Number64% Call Response Rate

Send SMS
Send Email
Send Payment
Leave a Message, we will call you back!
Send your enquiry to this supplier
terms privacy policy

We Accept Online Payments

All Rights Reserved (Terms of Use)